86 related articles for article (PubMed ID: 9435168)
21. Effect of radiation and age on immunoglobulin levels in rhesus monkeys (Macaca mulatta).
Stone WH; Saphire DG; Hackleman SM; Braun AM; Pennington P; Scheffler J; Wigle JC; Cox AB
Radiat Res; 1994 Jun; 138(3):401-8. PubMed ID: 8184015
[TBL] [Abstract][Full Text] [Related]
22. A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting.
Regeniter A; Kuhle J; Mehling M; Möller H; Wurster U; Freidank H; Siede WH
Clin Neurol Neurosurg; 2009 May; 111(4):313-8. PubMed ID: 19185983
[TBL] [Abstract][Full Text] [Related]
23. Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2.
Miederer M; McDevitt MR; Borchardt P; Bergman I; Kramer K; Cheung NK; Scheinberg DA
Clin Cancer Res; 2004 Oct; 10(20):6985-92. PubMed ID: 15501978
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of an intracerebroventricularly administered antibody in rats.
Noguchi Y; Kato M; Ozeki K; Ishigai M
MAbs; 2017 Oct; 9(7):1210-1215. PubMed ID: 28682148
[TBL] [Abstract][Full Text] [Related]
25. Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates.
Renbarger J; Aleksic A; McGuffey L; Dauser R; Berg S; Blaney S
Cancer Chemother Pharmacol; 2004 Jan; 53(1):39-42. PubMed ID: 14551735
[TBL] [Abstract][Full Text] [Related]
26. Formation, distribution, and elimination of infliximab and anti-infliximab immune complexes in cynomolgus monkeys.
Rojas JR; Taylor RP; Cunningham MR; Rutkoski TJ; Vennarini J; Jang H; Graham MA; Geboes K; Rousselle SD; Wagner CL
J Pharmacol Exp Ther; 2005 May; 313(2):578-85. PubMed ID: 15647331
[TBL] [Abstract][Full Text] [Related]
27. IgM anti-GQ1b monoclonal antibody inhibits voltage-dependent calcium current in cerebellar granule cells.
Nakatani Y; Murata M; Shibata K; Nagaoka T; Utsunomiya I; Usuki S; Miyatake T; Hoshi K; Taguchi K
Exp Neurol; 2009 Sep; 219(1):74-80. PubMed ID: 19306874
[TBL] [Abstract][Full Text] [Related]
28. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
[TBL] [Abstract][Full Text] [Related]
29. Immunospecific immunoglobulins and IL-10 as markers for Trypanosoma brucei rhodesiense late stage disease in experimentally infected vervet monkeys.
Ngotho M; Kagira JM; Jensen HE; Karanja SM; Farah IO; Hau J
Trop Med Int Health; 2009 Jul; 14(7):736-47. PubMed ID: 19573160
[TBL] [Abstract][Full Text] [Related]
30. [Investigation of herpes simplex virus in viral meningoencephalitis suspected cases using molecular and serological methods].
Akçali A; Ozkaya E; Yilmaz D; Uyar Y; Oncül O
Mikrobiyol Bul; 2008 Jul; 42(3):421-8. PubMed ID: 18822885
[TBL] [Abstract][Full Text] [Related]
31. Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery.
Pizzo ME; Wolak DJ; Kumar NN; Brunette E; Brunnquell CL; Hannocks MJ; Abbott NJ; Meyerand ME; Sorokin L; Stanimirovic DB; Thorne RG
J Physiol; 2018 Feb; 596(3):445-475. PubMed ID: 29023798
[TBL] [Abstract][Full Text] [Related]
32. Specific humoral immunity in mumps meningitis in children.
Kacprzak-Bergman I; Zaleska I; Jasonek J
Med Sci Monit; 2001; 7(5):977-81. PubMed ID: 11535945
[TBL] [Abstract][Full Text] [Related]
33. Low doses of antigen coupled to anti-CR2 mAbs induce rapid and enduring IgG immune responses in mice and in cynomolgus monkeys.
Whipple EC; Ditto AH; Shanahan RS; Gatesman JJ; Little SF; Taylor RP; Lindorfer MA
Mol Immunol; 2007 Jan; 44(4):377-88. PubMed ID: 16631928
[TBL] [Abstract][Full Text] [Related]
34. Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primates.
Warren KE; McCully C; Dvinge H; Tjørnelund J; Sehested M; Lichenstein HS; Balis FM
Cancer Chemother Pharmacol; 2008 Aug; 62(3):433-7. PubMed ID: 17960383
[TBL] [Abstract][Full Text] [Related]
35. Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity.
Driesse MJ; Esandi MC; Kros JM; Avezaat CJ; Vecht C; Zurcher C; van der Velde I; Valerio D; Bout A; Sillevis Smitt PA
Gene Ther; 2000 Aug; 7(16):1401-9. PubMed ID: 10981667
[TBL] [Abstract][Full Text] [Related]
36. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
37. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice.
Sheikh KA; Zhang G; Gong Y; Schnaar RL; Griffin JW
Ann Neurol; 2004 Aug; 56(2):228-39. PubMed ID: 15293275
[TBL] [Abstract][Full Text] [Related]
38. Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates.
Stapleton SL; Reid JM; Thompson PA; Ames MM; McGovern RM; McGuffey L; Nuchtern J; Dauser R; Blaney SM
Cancer Chemother Pharmacol; 2007 Mar; 59(4):461-6. PubMed ID: 16855840
[TBL] [Abstract][Full Text] [Related]
39. Protective anti-donor IgM production after crossmatch positive liver-kidney transplantation.
McAlister CC; Gao ZH; McAlister VC; Gupta R; Wright JR; MacDonald AS; Peltekian K
Liver Transpl; 2004 Feb; 10(2):315-9. PubMed ID: 14762873
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
